InvestLog
PCSA Processa Pharmaceuticals, Inc. logo

PCSA Processa Pharmaceuticals, Inc.

Healthcare
$2.50-5.66%ClosedMarket Cap: $5.7M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

13

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+23,141

Shares Acquired

23,141

Shares Disposed

0

Total Bought ($)

$13.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19Young Daviddirector, officer: Pres. Research & DevelopmentBuy1,545$2.9715,345
Tue May 19SKIBSTED RUSSELLofficer: Chief Financial OfficerBuy1,984$2.978,466
Tue May 19Ng George Kdirector, officer: Chief Executive OfficerBuy1,843$2.977,841
Tue May 19Lin Patrickofficer: Chief Business - Strategy OffBuy1,369$2.977,594
Tue May 19Guy Wendyofficer: Chief Administrative OfficerBuy1,583$2.978,011
Tue May 19Bigora Sianofficer: Chief Development OfficerBuy1,971$2.717,481
Fri May 01Young Daviddirector, officer: Pres. Research & DevelopmentBuy1,706$2.6913,813
Fri May 01SKIBSTED RUSSELLofficer: Chief Financial OfficerBuy2,190$2.696,498
Fri May 01Ng George Kdirector, officer: Chief Executive OfficerBuy2,034$2.696,013
Fri May 01Lin Patrickofficer: Chief Business - Strategy OffBuy1,511$2.696,236
Fri May 01Guy Wendyofficer: Chief Administrative OfficerBuy1,748$2.696,441
Fri May 01Bigora Sianofficer: Chief Development OfficerBuy1,986$2.697,496
Thu Apr 30Ng George Kdirector, officer: Chief Executive OfficerBuy2,136$2.542,136
Thu Apr 30Ng George Kdirector, officer: Chief Executive OfficerBuy1,843$2.973,979
Fri Apr 17Young Daviddirector, officer: Pres. Research & DevelopmentBuy1,545$2.9712,107